Novel Oral AntiCoagulants (NOAC) Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

99S3864250
67 Pages
May 2020
Healthcare

Download Sample Get Discount

Summary

According to 99Strategy, the Global Novel Oral AntiCoagulants (NOAC) Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Novel Oral AntiCoagulants (NOAC) market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Johnson & Johnson

Bristol-Myers Squibb

Boehringer Ingelheim

Sanofi

Daiichi Sankyo

Armatheon

Aspen

AstraZeneca

Bayer

Cellceutix

Cosmo Pharmaceuticals

CSL Behring

Eisai

GSK

Marathon Pharmaceuticals

Ockham Biotech

Perosphere

Key Product Type

Direct Thrombin Inhibitors

Direct Factor Xa Inhibitors

Market by Application

Deep Vein Thrombosis (DVT)

Pulmonary Embolism

Acute Coronary Syndrome

Hemodialysis

Others

Main Aspects covered in the Report

Overview of the Novel Oral AntiCoagulants (NOAC) market including production, consumption, status & forecast and market growth

2016-2020 historical data and 2021-2026 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

Impact of Coronavirus on the Industry

Table of Content

1 Industrial Chain Overview

1.1 Novel Oral AntiCoagulants (NOAC) Industry

1.1.1 Overview

Figure Novel Oral AntiCoagulants (NOAC) Picture List

1.1.2 Characteristics of Novel Oral AntiCoagulants (NOAC)

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Direct Thrombin Inhibitors

1.3.2 Direct Factor Xa Inhibitors

1.4 End-Use List

1.4.1 Demand in Deep Vein Thrombosis (DVT)

1.4.2 Demand in Pulmonary Embolism

1.4.3 Demand in Acute Coronary Syndrome

1.4.4 Demand in Hemodialysis

1.4.5 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2016-2026

Figure Global Market Size and Forecast with Growth Rate, 2016-2026

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026

Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026

Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2016-2020, in Volume

Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2016-2020, in Volume

Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD

Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2016-2020, in Volume

Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD

Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume

Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

3.2 Manufacturers List

3.2.1 Johnson & Johnson Overview

Table Johnson & Johnson Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Bristol-Myers Squibb Overview

Table Bristol-Myers Squibb Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bristol-Myers Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Boehringer Ingelheim Overview

Table Boehringer Ingelheim Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Sanofi Overview

Table Sanofi Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Daiichi Sankyo Overview

Table Daiichi Sankyo Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Daiichi Sankyo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Armatheon Overview

Table Armatheon Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Armatheon (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Aspen Overview

Table Aspen Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Aspen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 AstraZeneca Overview

Table AstraZeneca Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Bayer Overview

Table Bayer Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Bayer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Cellceutix Overview

Table Cellceutix Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cellceutix (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Cosmo Pharmaceuticals Overview

Table Cosmo Pharmaceuticals Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Cosmo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 CSL Behring Overview

Table CSL Behring Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of CSL Behring (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Eisai Overview

Table Eisai Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Eisai (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 GSK Overview

Table GSK Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of GSK (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Marathon Pharmaceuticals Overview

Table Marathon Pharmaceuticals Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Marathon Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Ockham Biotech Overview

Table Ockham Biotech Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Ockham Biotech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Perosphere Overview

Table Perosphere Overview List

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Novel Oral AntiCoagulants (NOAC) Business Operation of Perosphere (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2016-2020, in Volume

Figure Global Market Size and Growth Rate, 2016-2020, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2016-2020, in Volume

Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume

Figure Global Production Volume Share by Manufacturers in 2020, in Volume

Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD

Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD

Figure Global Production Amount Share by Manufacturers in 2020, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Direct Thrombin Inhibitors

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Direct Thrombin Inhibitors, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Direct Thrombin Inhibitors, 2016-2020, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Direct Factor Xa Inhibitors

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Direct Factor Xa Inhibitors, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Direct Factor Xa Inhibitors, 2016-2020, in Volume

5.2.2.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume

6.2 Segment Subdivision

6.2.1 Market in Deep Vein Thrombosis (DVT)

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Deep Vein Thrombosis (DVT), 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Deep Vein Thrombosis (DVT), 2016-2020, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Pulmonary Embolism

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Pulmonary Embolism, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Pulmonary Embolism, 2016-2020, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Acute Coronary Syndrome

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Acute Coronary Syndrome, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Acute Coronary Syndrome, 2016-2020, in Volume

6.2.3.2 Situation & Development

6.2.4 Market in Hemodialysis

6.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Hemodialysis, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Hemodialysis, 2016-2020, in Volume

6.2.4.2 Situation & Development

6.2.5 Market in Others

6.2.5.1 Market Size

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume

6.2.5.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2021-2026, in Million USD

Table Global Market Forecast by Region Segment 2021-2026, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2021-2026, in Million USD

Table Global Market Volume by Product Type Segment 2021-2026, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2021-2026, in Million USD

Table Global Market Volume by End-Use Segment 2021-2026, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the Novel Oral AntiCoagulants (NOAC) Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion

List of Table